Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors

Summary:

We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease (cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) in both skin and visceral cGVHD. The median time from transplant to initiation of ECP was 790 days. ECP was administered for 2 consecutive days every 2 weeks in 17 patients and once a week in eight patients until best response or stable disease. The median duration of therapy was 9 months (range 3–24 months). In all, 20 patients had improvement in cutaneous GVHD and six had healing of oral ulcerations. Steroid sparing or discontinuation of immunosuppressive medications was possible in 80% of patients. Response rates were similar between patients receiving treatment weekly vs every 2 weeks and in patients commencing ECP less than vs greater than 18 months from transplant (70 vs 66%). When patients were stratified based on the Akpek prognostic score, there was no difference in overall response between the favorable (Akpek score<2.5) and unfavorable risk groups, but patients with progressive onset cGVHD tended to have a higher response than those with de novo onset. In summary, we report improvement in skin and/or visceral cGVHD in 71% overall and 61% of high-risk patients.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Ferrara J, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.

    Article  CAS  PubMed  Google Scholar 

  2. Tsoi MS, Storb R, Dobbs S et al. Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease. J Immunol 1980; 125: 2258–2262.

    CAS  PubMed  Google Scholar 

  3. Alcindor T, Gorgun G, Miller K et al. Immunomodulatory effects of extracoroporeal photophoresis in patients with extensive chronic graft-versus-host disease. Blood 2001; 98: 1622–1625.

    Article  CAS  PubMed  Google Scholar 

  4. Vogelsang GB, Wolff D, Altomonte V et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant 1996; 17: 1061–1067.

    CAS  PubMed  Google Scholar 

  5. Eppinger T, Ehninger G, Steinert M et al. 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease. Transplantation 1990; 50: 807–811.

    Article  CAS  PubMed  Google Scholar 

  6. Aubin F, Brion A, Deconinck E et al. Phototherapy in the treatment of cutaneous graft-vs-host disease. Our preliminary experience in resistant patients. Transplantation 1995; 59: 151–155.

    Article  CAS  PubMed  Google Scholar 

  7. Jampel RM, Farmer ER, Vogelsang GB et al. PUVA therapy for chronic cutaneous graft-vs-host disease. Archi Dermatol 1991; 127: 1673–1678.

    Article  CAS  Google Scholar 

  8. Edelson R, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987; 316: 297–303.

    Article  CAS  PubMed  Google Scholar 

  9. Barr ML, Meiser BM, Eisen HJ et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998; 339: 1744–1751.

    Article  CAS  PubMed  Google Scholar 

  10. Barr ML, Baker CJ, Schenkel FA et al. Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation. Clin Transplant 2000; 14: 162–166.

    Article  CAS  PubMed  Google Scholar 

  11. Barr ML . Photopheresis for the prevention and treatment of transplant rejection. J Cutan Med Surg 2003.

  12. Costanzo-Nordin MR, Hubbell EA, O'Sullivan EJ et al. Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Preliminary clinical report. Circulation 1992; 86 (Suppl.): II242–II250.

    CAS  PubMed  Google Scholar 

  13. Costanzo-Nordin MR, Hubbell EA, O'Sullivan EJ et al. Successful treatment of heart transplant rejection with photopheresis. Transplantation 1992; 53: 808–815.

    Article  CAS  PubMed  Google Scholar 

  14. Costanzo-Nordin MR, McManus BM, Wilson JE et al. Efficacy of photopheresis in the rescue therapy of acute cellular rejection in human heart allografts: a preliminary clinical and immunopathologic report. Transplant Proc 1993; 25 (Part 2): 881–883.

    CAS  PubMed  Google Scholar 

  15. Dall'Amico R, Murer L, Montini G et al. Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol 1998; 9: 121–127.

    CAS  PubMed  Google Scholar 

  16. Dall'Amico R, Montini G, Murer L et al. Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection. Int J Artif Organs 2000; 23: 49–54.

    Article  CAS  PubMed  Google Scholar 

  17. DeNofrio D, Rosengard BR, Reynolds C et al. Rescue photochemotherapy for the treatment of acute cardiac rejection in the absence of cyclosporine maintenance therapy. J Heart Lung Transplant 1998; 17: 1036–1037.

    CAS  PubMed  Google Scholar 

  18. Rook AH, Wolfe JT . Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. J Clin Apheresis 1994; 9: 28–30.

    Article  CAS  PubMed  Google Scholar 

  19. Bladon J, Taylor PC . Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol 1999; 107: 707–711.

    Article  CAS  PubMed  Google Scholar 

  20. Aringer M, Granlinger WB, Smolen JS et al. Photophoresis treatment enhances CD95 (Fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br J Rheumatol 1997; 36: 1276–1282.

    Article  CAS  PubMed  Google Scholar 

  21. Dall'Amico R, Messina C . Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther Apher 2002; 6: 296–304.

    Article  CAS  PubMed  Google Scholar 

  22. Gorgun G, Miller KB, Foss FM . Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002; 100: 941–947.

    Article  CAS  PubMed  Google Scholar 

  23. Foss FM, Gorgun G, Miller KB . Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant 2002; 29: 719–725.

    Article  CAS  PubMed  Google Scholar 

  24. Child FJ, Ratnavel R, Watkins P et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1999; 23: 881–887.

    Article  CAS  PubMed  Google Scholar 

  25. Greinix H, Volc-Platzer B, Rabitsch W et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998; 92: 3098–3104.

    CAS  PubMed  Google Scholar 

  26. Greinix HT, Volc-Platzer B, Kalhs P et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 2000; 96: 2426–2431.

    CAS  PubMed  Google Scholar 

  27. Peters C, Minkov M, Gadner H et al. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplant 2000; 26: 405–411.

    Article  CAS  PubMed  Google Scholar 

  28. Ratanatharathorn V, Ayash L, Lazarus HM et al. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001; 28: 121–129.

    Article  CAS  PubMed  Google Scholar 

  29. Schooneman F, Claise C . Treatment of graft versus host disease (GVHD) by photopheresis? Transfus Sci 1996; 17: 527–536.

    Article  CAS  PubMed  Google Scholar 

  30. Dall'Amico R, Rossetti F, Zulian F et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 1997; 97: 848–854.

    Article  CAS  PubMed  Google Scholar 

  31. Knobler R . Extracorporeal photochemotherapy – present and future. Vox Sang 2000; 78 (Suppl. 2): 197–201.

    PubMed  Google Scholar 

  32. Owsianowski M, Gollnick H, Siegert W et al. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994; 14: 845–848.

    CAS  PubMed  Google Scholar 

  33. Rossetti F, Zulian F, Dall'Amico R et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation 1995; 59: 149–151.

    Article  CAS  PubMed  Google Scholar 

  34. Rossetti F, Dall'Amico R, Crovetti G et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996; 18 (Suppl. 2): 175–181.

    PubMed  Google Scholar 

  35. Rossetti F, Zulian F, Dall'Amico R et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous chronic graft-versus-host disease. Transplantation 1995; 59: 149–151.

    Article  CAS  PubMed  Google Scholar 

  36. Rossetti F, Dall'Amico R, Crovetti G et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996; 18 (Suppl. 2): 175–181.

    PubMed  Google Scholar 

  37. Russell-Jones R . Extracorporeal photophoresis in chronic cutaneous graft-versus-host disease. Bone Marrow Transplant 1998; 22: 621–623.

    Article  CAS  PubMed  Google Scholar 

  38. Apisarnthanarax N, Donato M, Korbling M et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003; 31: 459–465.

    Article  CAS  PubMed  Google Scholar 

  39. Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.

    CAS  PubMed  Google Scholar 

  40. Akpek G, Zahurak ML, Piantadosi S et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001; 97: 1219–1226.

    CAS  PubMed  Google Scholar 

  41. Lim HW, Edelson RL . Photophoresis for the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin N Am 1995; 9: 1117–1126.

    Article  CAS  Google Scholar 

  42. Wolfe JT, Lessin SR, Singh AH et al. Review of immunomodulation by photophoresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. Artif Organs 1994; 18: 888–897.

    CAS  PubMed  Google Scholar 

  43. Shlomchik WD, Couzens MS, Gang CB et al. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412–415.

    Article  CAS  PubMed  Google Scholar 

  44. Chan G, Gorgun G, Miller KB, Foss FM Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 170–176.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F M Foss.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Foss, F., DiVenuti, G., Chin, K. et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 35, 1187–1193 (2005). https://doi.org/10.1038/sj.bmt.1704984

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704984

Keywords

This article is cited by

Search

Quick links